Abstract
1,2,3,4-Tetrahydropyrimidine-2-thiones 4a–n were synthesized through the reaction of aromatic aldehydes 1a–n , ethyl acetoacetate (2) and thiourea ( 3) . The structures of all newly synthesized heterocyclic compounds elucidated by the use of IR, 1H NMR, mass spectra, and elemental analyses. The inhibitory activity against the Epstein-Barr Virus early antigen (EBA-VA) of all newly synthesized heterocyclic compounds were evaluated.
The authors are grateful to Molecular Biochemistry Department, Kyoto Prefectural University of Medicine, Kawarmachi-dori, Kamigyo-Ku, Kyoto, Japan for biological evaluation.